Research output per year
Research output per year
Search results
-
2023
Phase 2 Study of the Efficacy and Safety of Erdafitinib in Patients With Bacillus Calmette-Guérin (BCG)-Unresponsive, High-Risk Non–Muscle-Invasive Bladder Cancer (HR-NMIBC) With FGFR3/2 Alterations (alt) in THOR-2: Cohort 2 Interim Analysis Results
Catto, J. W. F., Tran, B., Master, V. A., Roupret, M., Pignot, G., Tubaro, A., Shimizu, N., Vasdev, N., Gschwend, J., Loriot, Y., Nishiyama, H., Redorta, J., Daneshmand, S., Miura, Y., Naini, V., Crow, L., Triantos, S., Baig, M. & Steinberg, G. D., 17 Feb 2023.Research output: Contribution to conference › Poster › peer-review